RVMD Competitors & Alternatives
Compare Revolution Medicines Inc with similar stocks in the same industry
Biotechnology
RVMD
Main Stock$205.89
Tradestie Score
53
Market Cap
$8.57B
Revenue Growth
-1.0%
Analyst Upside
+25.1%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
REGN
Regeneron Pharmaceuticals Inc
|
$734.81
|
$63.59B | 18.6 | 53 | Compare |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
$231.18
|
$60.38B | 44.2 | 47 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$936.00
|
$46.96B | 36.5 | 59 | Compare |
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$358.77
|
$36.81B | 65.5 | 52 | Compare |
|
INSM
Insmed, Inc.
|
$108.59
|
$31.13B | - | 58 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$96.85
|
$24.57B | - | 54 | Compare |
|
GMAB
Genmab A/S ADS
|
$34.55
|
$19.56B | 28.1 | 42 | Compare |
|
INCY
Incyte Genomics Inc
|
$117.14
|
$16.93B | 15.2 | 55 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$57.63
|
$15.70B | 31.4 | 66 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$16.69
|
$15.22B | - | 49 | Compare |
More RVMD Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2836)
228 stocks in this industry